7th Annual QT Prolongation and Safety Pharmacology
Swissôtel Le Plaza
BaselMesseplatz 25,
Basel,, Switzerland
QT Prolongation and Safety Pharmacology
Informa Life Sciences
Swissôtel Le Plaza 

Schedule of Presentations:

Wednesday, June 3, 2009
08:00:00 Conference registration and morning coffee
08:30:00 Opening remarks from the Chairperson
08:35:00 Conclusions from a review of ICH S7 guidelines Gerd Bode
09:05:00 Overview of recent Q&A with E14 working group and the impacts for your future trial designs Charles T Benson
09:35:00 Regulations Q&A
09:45:00 Effectively predicting QT prolongation in humans
10:20:00 Morning coffee
11:00:00 The translatability of existing and emerging preclinical cardiotoxicity assays Matthew J Killeen
11:35:00 Stem cells as a tool in preclinical testing for QT prolongation Martin Traebert
12:10:00 Spotlight session
12:45:00 Lunch
14:15:00 Bridging the gap between non-clinical and clinical studies Wilhelm Haverkamp
14:50:00 Drug induced QT/QTc prolongation - Review of one-stage vs. two-stage methods to analyse clinical ECG data Jianguo Li
15:25:00 Afternoon tea and high speed networking
16:05:00 Designing a tQT study for limited resources Arne Ring
16:40:00 Methods for reducing variability in QT assessment Henry Holzgrefe
17:15:00 Applications of mixed models in tQT studies Dennis Chanter
17:50:00 Closing remarks from the Chairperson
17:55:00 End of day one
Thursday, June 4, 2009
08:30:00 Opening remarks from the Chairperson
08:35:00 Assessing the risk of proarrythmia? Danshi Li
09:10:00 Three years post E14 guidance – Challenges and potential solutions Sasha Latypova
09:45:00 Cardiac safety strategies for FIM studies for biopharmaceuticals Alexander Breidenbach
10:20:00 Morning coffee and "meet the author" poster session
11:00:00 QT study design for oncology drugs Corina-Dana Dota,
11:30:00 Unwanted QT problems in oncology programmes - A hERG trafficking case study Bérengère Dumotier
12:00:00 Q&A session - What have we learned from oncology QT studies to date?
12:10:00 Spotlight session
12:45:00 Lunch
14:10:00 Drug related change in the ECG - A novel biomarker for cardiac risk? Christer Gottfridsson
14:45:00 Optimized Holter extractions in tQT studies Fabio Badilini
15:20:00 Afternoon tea
15:50:00 Increasing power through developing technologies - 12 lead ECG to continuous recording methods Corina-Dana Dota,
16:25:00 Assessing the risk of Na channel inhibition Danshi Li
17:00:00 Closing remarks from the Chairperson
17:10:00 End of conference
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.